Litcius/Paper detail

Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligo

Emma Guttman‐Yassky, Ester Del Duca, Joel Corrêa da Rosa, Jonathan Bar, Khaled Ezzedine, Zhan Ye, Wen He, Craig Hyde, Mina Hassan‐Zahraee, Yuji Yamaguchi, Elena Peeva

2023Journal of Allergy and Clinical Immunology44 citationsDOIOpen Access PDF

Topics & Concepts

VitiligoTECMelanocyteImmune systemCancer researchMedicineImmunologyMelanomaAstronomyIonospherePhysicsmelanin and skin pigmentationMast cells and histamineMelanoma and MAPK Pathways
Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligo | Litcius